Surmodics Inc (SRDX) Return on Equity ROE from the third quarter 2025 to third quarter 2024 and annually, average high and low, overall ranking from Jun 30 2025 to Jun 30 2024 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Surmodics Inc   (NASDAQ: SRDX)

Surmodics Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Surmodics Inc in the third quarter 2025?
Surmodics Inc recorded a cumulative net loss of $-18 million during 12 months ending in the third quarter 2025, resulting in a negative return on equity (ROE) of -15.59%.

Within the Medical Equipment & Supplies industry 78 other companies had a higher return on equity. While Return on equity, overall ranking has advanced in the quarter, so far to 2510, from total ROE ranking in the second quarter 2025 at 2573.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jun 30 2025)
III. Quarter		 (Mar 31 2025)
II. Quarter		 (Dec 31 2024)
I. Quarter		 (Sep 30 2024)
IV. Quarter		 (Jun 30 2024)
III. Quarter
Y / Y Equity Change -5.79 % -11.06 % -8.5 % -0.84 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -18 -20 -14 -12 -1
Return On Equity (TTM) -15.59 % -17.31 % -12.19 % -9.56 % -1.16 %
SRDX's Total Ranking # 2510 # 2573 # 353 # 0 # 1284
Equity (TTM) in Millions 111 110 112 119 118
Seq. Equity Change 0.96 % -1.36 % -6 % 0.64 % -4.68 %
Seq. Net Income Change - - - - -

Back to SRDX Management Effectiveness >> SRDX's 5 Years Annual ROE >> Compare SRDX ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 79
Sector # 226
Overall # 2510

Return On Equity Statistics
High Average Low
15.2 %
1.52 %
-32.44 %
(Dec 31 2013)   (Mar 31 2023)





SRDX Annual Return On Equity (Sep 30 2024)
2024		 (Sep 30 2023)
2023		 (Sep 30 2022)
2022		 (Sep 30 2021)
2021		 (Sep 30 2020)
2020
Total Equity in Millions 119 120 108 140 131
Y / Y Equity Change -0.84 % 10.63 % -22.62 % 6.89 % 6.97 %
Net Income in Millions -12 -2 -27 4 1
Y / Y Net Income Change - - - 277.29 % -85.21 %
Return On Equity -9.71 % -1.28 % -25.16 % 3.02 % 0.86 %

Back to SRDX Management Effectiveness >> SRDX's 5 Years Annual ROE >> Compare SRDX ROE to its Competitors




More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
SRDX's' Return on Equity at Yahoo Finance
SRDX's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for SRDX's Competitors
Subscribers only: Roe for Surmodics Inc 's Suppliers
Subscribers only: Return On Equity for SRDX's Customers




Companies with similar Return On Equity at Jun 30 2025, within Healthcare Sector ROE

Date modified: 2026-09-26T06:54:28+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.